#1 prescribed treatment for
Huntington's disease (HD) chorea*

*Time period 05/2022 through 07/2024.
AUS-47394 September 2024

for HD Chorea in Adults

People taking AUSTEDO XR reported being more physically capable of performing everyday tasks2*

Find out more
9 out of 10 people using Austedo XR reported improvement in movement control

People on AUSTEDO XR said their movement control had improved since starting treatment2*

See study results

*Results from a real-world survey including 31 patients with HD chorea taking AUSTEDO XR.

Austedo XR offers personalized dosing schedule

AUSTEDO XR offers a personalized approach
to dosing1

Learn how
More
than 90%
of people pay
$ or less per month for AUSTEDO XR2,†
Discover the benefits

Additional financial assistance support is available for eligible patients. Certain restrictions apply.
See terms and conditions on AUSTEDOcardform.com

References:

1. AUSTEDO XR® (deutetrabenazine) extended-release tablets/AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ: Teva Neuroscience, Inc.

2. Data on file. Parsippany, NJ: Teva Neuroscience, Inc.